作为COVID-19后综合征 (或长期COVID) 的潜在治疗方法的血清激素精神药物:综合性综述
Zhen Xuen Brandon Low1, Shin Jie Yong2, Hayam A Alrasheed3
1Jeffrey Cheah School of Medicine and Health Sciences, Monash University Malaysia, Selangor, Malaysia.
Progress in neuro-psychopharmacology & biological psychiatry
|February 5, 2025
概括
血清色精神药物可以通过向炎症和神经可塑性来帮助治疗长期COVID (后COVID-19综合征). 需要进一步的研究来确认它们对这些持续的COVID-19后症状的安全性和有效性.
科学领域:
- 神经科学是一个神经科学.
- 药理学 药理学是指药理学的学科.
- 免疫学 免疫学 免疫学
背景情况:
- 后COVID-19综合征 (PCS) 或长期COVID,在急性感染后呈现持续的衰弱症状.
- 目前对PCS缺乏治疗方法,造成了大量未满足的医疗需求.
- 较低的血清激素水平与PCS严重程度相关,这表明治疗目标.
研究的目的:
- 探索色胺类精神药物对PCS的潜在治疗机制.
- 确定这些化合物如何缓解常见的长期COVID症状.
主要方法:
- 文献综述现有关于血清激素类迷幻药物和PCS的研究.
- 分析拟议的机制,包括对炎症,神经可塑性和肠道健康的影响.
主要成果:
- 血清催化剂可减少炎症和改善神经可塑性,可能减轻PCS.
- 这些化合物也可能解决内皮功能障碍,这是PCS相关器官问题的关键因素.
- 潜在的好处延伸到特定的症状,如嗅觉功能障碍,认知障碍,睡眠问题和心理健康挑战.
结论:
- 新出现的证据表明,色胺类迷幻药在缓解PCS症状方面表现有前途.
- 高质量的临床试验对于验证这些药物在长期COVID治疗中的安全性和有效性至关重要.
相关概念视频
Antidepressant Drugs: MAOIs and Other Agents
183
Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...
183
Antidepressant Drugs: Tricyclics, SSRIs, and SNRIs
289
Tricyclic Antidepressants (TCAs), including Desipramine (Norpramin), Imipramine (Tofranil), Clomipramine (Anafranil), and Amitriptyline (Elavil), inhibit serotonin and norepinephrine reuptake and also block other receptors. They are used for depression, pain conditions, and insomnia. Common adverse effects include anticholinergic effects, sedation, orthostatic hypotension, and weight gain. They have a narrow therapeutic window and so require plasma-level monitoring. Abrupt discontinuation can...
289
CNS Stimulants: Psychedelic Agents
121
Hallucinogens, also known as psychedelic drugs, are a class of substances known for their ability to alter perception, cognition, and emotions. Despite their profound effects on the mind, these drugs are non-addictive, setting them apart from many other abused substances. The mechanism of action of these drugs lies in their impact on the 5-HT2A receptor in the brain. Upon activation, this receptor couples to Gq-type G proteins, triggering a cascade that releases intracellular calcium. This...
121
Sedatives and Hypnotics Drugs: Miscellaneous Agents
144
Sedatives and hypnotics encompass a wide range of substances, each with its unique mechanism of action, uses, and potential adverse effects.
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
144
Electroconvulsive Therapy
22
Electroconvulsive therapy (ECT), or shock therapy, remains a critical biomedical intervention for severe, treatment-resistant depression. While its origins can be traced back to Hippocrates' observations that malaria-induced convulsions alleviated mental illness, modern ECT has evolved significantly from its earlier, more primitive applications. First introduced in 1938 by Ugo Cerletti and his colleagues, ECT involves inducing controlled seizures using electrical currents. In its early...
22
G-protein Coupled Receptors
114.9K
G-protein coupled receptors are ligand binding receptors that indirectly affect changes in the cell. The actual receptor is a single polypeptide that transverses the cell membrane seven times creating intracellular and extracellular loops. The extracellular loops create a ligand specific pocket which binds to neurotransmitters or hormones. The intracellular loops holds onto the G-protein.
114.9K


